Last $28.96 USD
Change Today +0.135 / 0.47%
Volume 10.2M
PFE On Other Exchanges
Symbol
Exchange
New York
Xetra
Mexico
SIX Swiss Ex
Stockholm
London
Sao Paulo
Bogota
As of 2:20 PM 08/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Barbara J. Dalton Ph.D.

Head of In-house Venture Capital Arm, Pfizer Inc.
AgeTotal Calculated CompensationThis person is connected to 118 board members in 3 different organizations across 7 different industries.

See Board Relationships
61--

Background*

Dr. Barbara J. Dalton, Ph.D. serves as a Venture Investment Lead of Pfizer Venture Investments. Dr. Dalton served as the Vice President of Venture Capital at Pfizer Venture Investments. Dr. Dalton has been Head of In-house Venture Capital Arm at Pfizer Inc. since July 16, 2007. She is employee at Vermillion, Inc. She served as President of SR One. Dr. Dalton served as the President at Mid-Atlantic Capital Alliance and EuclidSR Partners, L.P. She was a General Partner ...

Read Full Background

Corporate Headquarters*

235 East 42nd Street
New York, New York 10017

United States

Phone: 212-733-2323
Fax: --

Board Members Memberships*

Former President and Director
Prior
Director
Former Director
Director
Former Chairman
Former Director
Former Member of the Board of Directors
Director
Director
Member of Board of Managers
2012-2014
Former Director

Education*

Unknown/Other Education
Pennsylvania State University
PhD
Drexel University College of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PFE:US $28.97 USD +0.15

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
Kenneth C. Frazier Chairman and Chief Executive Officer
Merck & Co. Inc.
$1.5M
Joseph Jimenez MBAChief Executive Officer and Member of Executive Committee
Novartis AG
SFr.3.1M
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
SFr.5.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PFIZER INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.